Male Stress Urinary Incontinence

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

GT Biopharma
GT BiopharmaSAN FRANCISCO, CA
1 program
GTU Artificial Urinary SphincterN/A1 trial
Active Trials
NCT02288455CompletedEst. Nov 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GT BiopharmaGTU Artificial Urinary Sphincter

Clinical Trials (1)

NCT02288455GT BiopharmaGTU Artificial Urinary Sphincter

Clinical Investigation of GT UrologIcal, LLC's Artificial Urinary Sphincter (RELIEF II)

Start: Oct 2014Est. completion: Nov 2017
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space